Webster Brian Daniel 4

What Happened
Brian Daniel Webster, President, Chief Executive Officer and a director of Kestra Medical Technologies, sold a total of 15,000 shares in two open-market transactions on May 15, 2026. He sold 8,155 shares at $20.53 per share (proceeds $167,412) and 6,845 shares at $21.46 per share (proceeds $146,918), for aggregate proceeds of approximately $314,330. These were sales (not purchases), which are often routine dispositions.

Key Details

• Transaction date: 2026-05-15; Form 4 filed: 2026-05-18 (within normal reporting timeframe).
• Trade breakdown:
  • 8,155 shares sold at $20.53 — reported proceeds $167,412. (Footnote: weighted-average price; reported price range $20.2200 to $20.2115.)
  • 6,845 shares sold at $21.46 — reported proceeds $146,918. (Footnote: weighted-average price; reported price range $21.2433 to $21.6300.)
• Total shares sold: 15,000; total proceeds: ~$314,330.
• Reported as occurring under a Rule 10b5‑1 trading plan adopted September 29, 2025 (pre-arranged trading plan).
• Shares owned after the transaction are not specified in the summary provided.

Context
Sales executed under a 10b5‑1 plan are pre-scheduled and commonly used by insiders to systematically sell holdings; they do not necessarily indicate a change in view on the company. This filing documents routine insider selling rather than a purchase or option exercise.